The ADC Cytotoxic Payloads / Warheads market is anticipated to grow a sustained rate, claims Roots Analysis
With six approved drugs, namely POLIVY™, LUMOXITI™, BESPONSA ® , MYLOTARG™, KADCYLA ® , ADCETRIS® and over 300 drugs underdevelopment, antibody drug conjugates (ADCs) have emerged as a promising class of targeted therapies for various disease indications Roots Analysis is pleased to announce the publication of its recent study, titled, ADC Cytotoxic Payloads / Warheads: Products and Services Market, 2021-2030 .” The report features an extensive study on the current market landscape, offering an informed opinion on the likely future potential of ADC cytotoxic payloads / warhead s providers, over the next decade. The study underlines an in-depth analysis, highlighting the diverse capabilities of various industry stakeholders engaged in this field. In addition to other elements, the report includes: § A detailed assessment of the current market landscape of ADC cytotoxic payloads / warheads. § A competitiveness analysis of ADC cytotoxic payloads / warheads